BioAlliance Pharma Provides An Update On Its Partnerships For Loramyc®/Oravig®

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, updates on Loramyc®/Oravig® development programs by its Asian partners and on its US partnership.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC